Hetlioz and Sertraline drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Hetlioz (tasimelteon) and Sertraline (sertraline hydrochloride). Common drug interactions include sleep apnoea syndrome among females and insomnia among males.
The phase IV clinical study analyzes what interactions people have when they take Hetlioz and Sertraline. It is created by eHealthMe based on reports of 93 people who take the same drugs from the FDA, and is updated regularly.
What is Hetlioz?
Hetlioz has active ingredients of tasimelteon. eHealthMe is studying from 7,418 Hetlioz users. Check the latest studies of Hetlioz.
What is Sertraline?
Sertraline has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 153,305 Sertraline users. Check the latest studies of Sertraline.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
93 people who take Hetlioz and Sertraline together, and have interactions are studied.

What are the common drug interactions of Hetlioz and Sertraline, by gender? *:
female:
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
- Surgery
- Throat tightness
- Weight increased
- Insomnia (sleeplessness)
- Drug ineffective
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Sleep disorder
- Abnormal dreams
- Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
male:
- Insomnia (sleeplessness)
- Oesophageal carcinoma (cancer tumour of oesophagus)
- Nightmare (unpleasant dream)
- Diarrhoea
- Dysarthria (speech disorder)
- Fall
- Hypersensitivity
- Ingrowing nail
- Initial insomnia (feeling of inadequate or poor-quality sleep)
- Intentional self-injury
What are the common drug interactions of Hetlioz and Sertraline, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Decreased appetite
- Insomnia (sleeplessness)
- Aggression
- Mood swings (an extreme or rapid change in mood)
- Poor quality sleep
- Affect lability (emotional incontinence)
- Restless legs syndrome (a powerful urge to move your legs)
- Tardive dyskinesia (a disorder that involves involuntary movements)
- Weight decreased
- White blood cell count decreased
50-59:
- Drug ineffective
- Headache (pain in head)
- Abnormal dreams
- Nocturia (the need to get up in the night to urinate)
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
- Urinary tract infection
- Abdominal discomfort
- Choking sensation (feeling of obstruction in respiratory system)
- Dyspepsia (indigestion)
- Insomnia (sleeplessness)
60+:
- Drug ineffective
- Oesophageal carcinoma (cancer tumour of oesophagus)
- Bladder discomfort
- Blood pressure fluctuation
- Cough
- Dehydration (dryness resulting from the removal of water)
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
- Dry mouth
- Fatigue (feeling of tiredness)
- Gastric disorder (disease of stomach)
What are the existing conditions these people have? *
- Circadian Rhythm Sleep Disorder (family of sleep disorders affecting, among other things, the timing of sleep): 26 people, 27.96%
* Approximation only. Some reports may have incomplete information.
Do you take Hetlioz and Sertraline?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Hetlioz (7,418 reports)
- Sertraline (153,305 reports)
Browse all drug interactions of Hetlioz and Sertraline:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Hetlioz:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Sertraline:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Hetlioz and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sertraline and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
- Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on tasimelteon and sertraline hydrochloride (the active ingredients of Hetlioz and Sertraline, respectively), and Hetlioz and Sertraline (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ocrevus and Nose Bleed for Women aged 60+ - 20 seconds ago
- Ocrevus and Nose Bleeds for Women aged 60+ - 20 seconds ago
- Ocrevus and Nosebleeds for Women aged 60+ - 20 seconds ago
- Ocrevus and Epistaxis for Women aged 60+ - 21 seconds ago
- Ocrevus and Bleeding From The Nose for Women aged 60+ - 21 seconds ago
- Ocrevus and Nosebleed for Women aged 60+ - 21 seconds ago
- Drug interactions of Cranberry and Miconazole Nitrate - 29 seconds ago
- Drug interactions of Sodium Chloride and Meperidine Hydrochloride - 37 seconds ago
- Lexapro and Ataxia Aggravated for Women aged 60+ - 40 seconds ago
- Sertraline and Biktarvy drug interactions for men aged 40-49 - 49 seconds ago